Cost-effectiveness analysis of hepatitis B vaccination strategies in Catalonia, Spain (Q77051038)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10155330%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

title

Cost-effectiveness analysis of hepatitis B vaccination strategies in Catalonia, Spain (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10155330%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10155330%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

author name string

R Garuz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10155330%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

J Rovira

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10155330%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

F Antón

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10155330%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

C Trinxet

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10155330%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

E Navas

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10155330%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

L Salleras

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10155330%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

publication date

1 May 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10155330%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10155330%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10155330%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10155330%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

page(s)

428-443

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10155330%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00019053-199507050-00007

2 December 2019

exact match

0 references

cites work

A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis

1 reference

12 December 2020

Cost effectiveness of antenatal hepatitis B screening and vaccination of infants

1 reference

12 December 2020

Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis

1 reference

12 December 2020

Global control of hepatitis B through vaccination: role of hepatitis B vaccine in the Expanded Programme on Immunization

1 reference

12 December 2020

Summary of clinical findings on Engerix-B, a genetically engineered yeast derived hepatitis B vaccine

1 reference

12 December 2020

Hepatitis B infection in sub-Saharan Africa. The African Regional Study Group

1 reference

12 December 2020

Cost-benefit analysis of a nationwide inoculation programme against viral hepatitis B in an area of intermediate endemicity

1 reference

12 December 2020

[How and who should be vaccinated against hepatitis B in Spain?]

1 reference

12 December 2020

Cost-benefit analysis of a nationwide neonatal inoculation programme against hepatitis B in an area of intermediate endemicity

1 reference

12 December 2020

Cost-benefits of vaccination against hepatitis B in hospital personnel in Venezuela

1 reference

12 December 2020

Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis.

1 reference

12 December 2020

Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver

1 reference

12 December 2020

Hepatitis B vaccine: a pharmacoeconomic evaluation of its use in the prevention of hepatitis B virus infection

1 reference

12 December 2020

Prevalence of hepatitis B markers in the population of Catalonia (Spain). Rationale for universal vaccination of adolescents

1 reference

12 December 2020

Cost-benefit analysis of the introduction of mass vaccination against hepatitis B in Italy

1 reference

12 December 2020

A simplified financial cost-effectiveness analysis of programs for prevention of hepatitis B accidental inoculation among hospital personnel in Thailand

1 reference

12 December 2020

Update on hepatitis B prevention. Recommendations of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services

1 reference

12 December 2020

Is vaccination against hepatitis B efficient? A review of world literature

1 reference

12 December 2020

Virus hepatitis B, A, non-A, non-B.

1 reference

12 December 2020

[The epidemiology of hepatitis B in Spain]

1 reference

12 December 2020

Benefit-Cost Analysis of Hepatitis B Vaccine Programs for Occupationally Exposed Workers

1 reference

12 December 2020

Cost-Benefit Analysis of Hepatitis-B Vaccination: A Computerized Decision Model for Spain

1 reference

12 December 2020

Foundations of Cost-Effectiveness Analysis for Health and Medical Practices

1 reference

12 December 2020

Cost-Effectiveness of Hepatitis-B Vaccine in Greece: A Country of Intermediate HBV Endemicity

1 reference

12 December 2020

Hepatitis B virus infection. Current concepts of chronicity and immunity

1 reference

12 December 2020

Eradication of hepatitis B in Portugal. A challenge within reach of the National Health Service

1 reference

12 December 2020

Cost effectiveness of intradermal vs. subcutaneous hepatitis b vaccination for the mentally handicapped

1 reference

12 December 2020

Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP)

1 reference

12 December 2020